Accendra Health names Kenneth Gardner-Smith CEO on October 5, 2026; Pesicka to advise up to 30 months

ACCENDRA HEALTH INC/VA/

Kenneth Gardner-Smith was named President and CEO, with a mutually agreed start date of October 5, 2026; Edward A. Pesicka remains CEO until then.
Pesicka will retire from the Board on October 5, 2026 and entered a September 28, 2026 consulting agreement to serve as an advisor for up to thirty months.
The consulting term ends on the earlier of March 31, 2029, Pesicka's death or disability, or an uncured material breach 30 days after notice.
Pesicka's outstanding equity awards remain outstanding and continue to vest during the consulting term; he will receive the COBRA Benefit for up to 18 months.
The agreement includes a release of claims and keeps non-competition, non-solicitation, and confidentiality covenants from his March 9, 2026 Leadership Teammate Agreement.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.